Status:
COMPLETED
Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver
Lead Sponsor:
Ain Shams University
Conditions:
Fatty Liver
Eligibility:
All Genders
6-16 years
Phase:
NA
Brief Summary
this is a prospective, interventional, open-label, randomized study on the efficacy of omega 3 fatty acids supplementation in Egyptian children with non-alcoholic fatty liver disease who had been sele...
Eligibility Criteria
Inclusion
- Children between 5 - 16 years old with diffusely hyper echogenic liver at ultrasonography were included in the study.
Exclusion
- Patients with secondary causes of steatosis including total parenteral nutrition, drugs causing fatty liver disease for example steroids, hepatitis A, B, C, cytomegalovirus, Epstein-Barr virus infections, autoimmune liver disease, metabolic liver diseases, Wilson's disease, and alpha-1-antitrypsin deficiency.
- Patients currently taking fish oil supplements.
- Patients with systemic illness such as cardiac and kidney diseases.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 19 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04281121
Start Date
March 1 2019
End Date
February 19 2020
Last Update
February 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatrics hospital Ain shams University
Cairo, Egypt